Acesso livre
Acesso livre

Arquivos do dia: Agosto 24, 2021

[Preprint] Estudo randomizado | Fluvoxamina reduz o risco de hospitalização em pacientes com Covid-19.

24 Ago, 2021 | 11:54h

RCT: Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19 – Together Clinical Trials

Conteúdos relacionados:

Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine).

Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19

 

Comentário no Twitter

 

Reforço de vacinas contra Covid-19: o que se sabe e quem está fazendo o quê.

24 Ago, 2021 | 11:52h

Covid-19 booster vaccines: What we know and who’s doing what – The BMJ

OMS pede uma pausa de 2 meses nas doses de reforço das vacinas em países ricos para que pessoas em países pobres possam receber as primeiras doses.

24 Ago, 2021 | 11:51h

WHO head calls for two-month vaccine booster moratorium – Associated Press

Opinião | O FDA realmente precisava demorar tudo isso – “Se a aprovação das vacinas parece tão escrupulosa, é porque a alternativa a isso é pior.”

24 Ago, 2021 | 11:49h

The FDA Really Did Have to Take This Long – The Atlantic

Como a variante Delta evoluirá? Isto é o que a teoria nos diz.

24 Ago, 2021 | 11:48h

How will Delta evolve? Here’s what the theory tells us – The Conversation

Vacinas contra COVID protegem da variante Delta, mas sua eficácia diminui com o tempo.

24 Ago, 2021 | 11:47h

COVID vaccines protect against Delta, but their effectiveness wanes – Nature

Estudo original: [Preprint] Pfizer vaccine effectiveness against Delta declines faster than AstraZeneca, both offering the same protection after 4 months.

Como fazer: considerações sobre transplante pulmonar para pacientes com COVID-19.

24 Ago, 2021 | 11:45h

How I Do It: Considering lung transplantation for patients with COVID-19 – CHEST

 

Conteúdos relacionados:

Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries

Report: Lung transplantation for 3 patients with severe COVID-19

Perspectiva | Como escolas e creches devem lidar com resfriados em tempos de Covid? É complicado. – “Cada tosse ou nariz escorrendo será tratado como potencial Covid até que se prove o contrário?”

24 Ago, 2021 | 11:43h

How Should Schools And Daycare Treat Colds In The Covid Age? It’s Complicated. – Romper

Desfechos em 30 dias de crianças e adolescentes com COVID-19: uma experiência internacional – “Apesar da fatalidade insignificante, complicações como hospitalização, hipoxemia e pneumonia foram mais frequentes em crianças e adolescentes com COVID-19 do que em casos de influenza.”

24 Ago, 2021 | 11:42h

Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience – Pediatrics

Conteúdos relacionados:

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

AAP Guidance: Post-COVID-19 conditions in children and adolescents.

Cohort study: Risk factors for long covid in previously hospitalized children.

Cohort study: Neurological manifestations of SARS-CoV-2 infection in hospitalized children and adolescents in the UK – “around 1 in 20 of children hospitalized with COVID-19 develop brain or nerve complications linked to the viral infection”.

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Deaths from COVID ‘incredibly rare’ among children.

[Preprint] Study confirms children’s extremely low risk of death from Covid-19 – “99·995% of children and young people with a positive SARS-CoV-2 test survived”.

Atualização de prática clínica da AGA sobre avaliação e tratamento de complicações iniciais após cirurgia bariátrica/metabólica.

24 Ago, 2021 | 11:40h

AGA Clinical Practice Update on Evaluation and Management of Early Complications After Bariatric/Metabolic Surgery: Expert Review – Clinical Gastroenterology and Hepatology

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.